Etonogestrel implant (Implanon) for contraception.
Journal: 2001/September - Drug and Therapeutics Bulletin
ISSN: 0012-6543
PUBMED: 11526801
Abstract:
Levonorgestrel 38 mg subdermal implant (Norplant), intended to provide contraception for 5 years, was withdrawn in the UK in 1999 due to unwanted effects (menstrual disturbances) and difficulties in removing the device. Since then, [symbol: see text]etonogestrel implant (Implanon-Organon), another progestogen--only subdermal contraceptive device, has become available in the UK. The manufacturer claims that etonogestrel implant provides contraception for up to 3 years and is easy to insert and remove. Here, we consider the place of etonogestrel implant.
Relations:
Citations
(1)
Drugs
(3)
Chemicals
(4)
Organisms
(1)
Processes
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.